immuron - Robuta Search

https://www.nasdaq.com/market-activity/stocks/imrn/institutional-holdings Immuron Limited American Depositary Shares (IMRN) Institutional Holdings | Nasdaq Find the latest institutional holdings data for Immuron Limited American Depositary Shares (IMRN) including shareholders, ownership summaries, and holding... american depositary shares institutional holdings immuron limited imrn https://www.barchart.com/futures/quotes/IMRN/competitors?quoteSectors=-283E IMRN Competitors for Immuron Ltd ADR Stock - Barchart.com Competitors for Immuron Ltd ADR (IMRN): view how companies in the same sector perform against each other. imrn competitors immuron ltd adr https://www.biospace.com/immuron-limited-to-present-at-the-emerging-growth-conference-may-07-2024 Immuron Limited to Present at the Emerging Growth Conference - May 07, 2024 - BioSpace May 7, 2024 - Immuron Limited, an Australian based and globally integrated biopharmaceutical company is pleased to invite individual and institutional investors as well as... https://www.macrotrends.net/stocks/charts/IMRN/immuron/net-profit-margin IMMURON Net Profit Margin 2018-2025 | IMRN | MacroTrends IMMURON net profit margin from 2018 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. net profit margin 2018 2025 immuron imrn macrotrends https://www.macrotrends.net/stocks/charts/IMRN/immuron/price-sales IMMURON Price to Sales Ratio 2018-2025 | IMRN | MacroTrends price to sales ratio 2018 2025 immuron imrn macrotrends https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/emerging-growth-research-issues-flash-update-on-immuron-limited-maint-1144086 Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and... NEW YORK CITY, NEW YORK / ACCESS Newswire / March 5, 2026 / Emerging Growth Research today released a Flash Research Update on Immuron Limited (Nasdaq:IMRN),... https://www.biospace.com/immuron-ceo-steven-lydeamore-to-present-at-h-c-wainwright-september-11-2023 Immuron CEO, Steven Lydeamore to present at H.C. Wainwright - September 11, 2023 - BioSpace Sep 11, 2023 - Immuron Limited, an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will... https://theorg.com/org/immuron Immuron | The Org Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company (ASX: IMC) focused on oral immunotherapy using polyclonal antibody products... immuron https://www.benzinga.com/general/biotech/22/01/25014682/immuron-shares-rally-on-us-department-of-defense-funding-of-a-6-2m Immuron Shares Rally On US Department Of Defense Funding Of A$6.2M - Immuron (NASDAQ:IMRN) -... Jan 12, 2022 - Immuron Limited (NASDAQ: IMRN) has us department of defense https://www.ig.com/en-ch/shares/markets-shares/immuron-limited1 Trade Immuron Limited Shares | Live Immuron Limited Share Price | IG Switzerland | IG Bank... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal... [EN-CH] live share trade immuron limited shares https://www.biospace.com/immuron-ceo-steven-lydeamore-to-present-at-peak-sky-high Immuron CEO Steven Lydeamore to present at Peak Sky High - BioSpace May 31, 2024 - Immuron Limited, an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will... sky high immuron ceo steven